Application Prospect of Integrative Omics in Forensic Identification of Methamphetamine-Associated Psychosis

doi:10.12116/j.issn.1004-5619.2021.101201

Abstract

Abstract:

The clinical symptoms and signs of methamphetamine-associated psychosis （MAP） and schizophrenia are highly similar, but the situation is completely different when MAP and schizophrenia patients need to be assessed for criminal responsibility after they comitted a harmful behavior. Therefore, the distinction between the two psychoses is very important in forensic psychiatry. At present, the identification of these two psychoses is mainly dependent on the corresponding criteria such as the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition （DSM-5） and the Chinese Classification of Mental Disorders Version 3 （CCMD-3）. It’s challenging to diagnose and distinguish between the two in practical cases due to their similar clinical symptoms and the lack of effective objective indexes. Different from the limitations of single omics, integrative omics intergrates data from multiple dimensions and has been extensively studied in the field of schizophrenia and has achieved some preliminary results. In view of the correlation between MAP and schizophrenia and the potential application value of integrative omics, this paper proposes an integrative omics strategy for MAP pathogenesis and forensic identification, aiming to improve the further understanding of the relationship between the two psychoses and the corresponding pathogenesis. It also provides references for the future exploration of integrative omics in forensic precise identification and effective monitoring and early warning methods.

Key words: forensic psychiatry, methamphetamine-associated psychosis, schizophrenia, integrative omics, review

CLC Number:

DF795.1

Long-rui ZHAO, Jian-bo ZHANG, Wei HAN, Li ZHU, Teng CHEN, Fang-lin GUAN. Application Prospect of Integrative Omics in Forensic Identification of Methamphetamine-Associated Psychosis[J]. Journal of Forensic Medicine, 2022, 38(5): 650-656.

References 54

1	2019年中国毒品形势报告[R].
	2020-06-28[2022-06-20]. .
	Report on the drug situation in China in 2019[R].
	2020-06-28[2022-06-20]. .
2	ZWEBEN J E， COHEN J B， CHRISTIAN D， et al. Psychiatric symptoms in methamphetamine users[J]. Am J Addict，2004，13（2）：181-190. doi：10.1080/10550490490436055 .
3	MCKETIN R， MCLAREN J， LUBMAN D I， et al. The prevalence of psychotic symptoms among methamphetamine users[J]. Addict Abingdon Engl，2006，101（10）：1473-1478. doi：10.1111/j.1360-0443. 2006.01496.x .
4	MCKETIN R， LUBMAN D I， NAJMAN J M， et al. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study[J]. Addiction，2014，109（5）：798-806. doi：10.1111/add.12474 .
5	FLECKENSTEIN A E， VOLZ T J， RIDDLE E L， et al. New insights into the mechanism of action of amphetamines[J]. Annu Rev Pharmacol Toxicol，2007，47：681-698. doi：10.1146/annurev.pharmtox.47.120505.105140 .
6	IZAWA J I， YAMANASHI K， ASAKURA T， et al. Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3，4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats[J]. Eur J Pharmacol，2006，549（1/2/3）：84-90. doi：10.1016/j.ejphar.2006.08.031 .
7	MCINTOSH C N. Methamphetamine： its history， pharmacology， and treatment[J]. Drug Alcohol Rev，2010，29（4）：464-466. doi：10.1111/j.1465-3362.2010. 00211_3.x .
8	LECOMTE T， DUMAIS A， DUGRÉ J R， et al. The prevalence of substance-induced psychotic disorder in methamphetamine misusers： A meta-analysis[J]. Psychiatry Res，2018，268：189-192. doi：10.1016/j.psychres.2018.05.033 .
9	MCKETIN R， BAKER A L， DAWE S， et al. Differences in the symptom profile of methampheta-mine - related psychosis and primary psychotic disorders[J]. Psychiatry Res，2017，251：349-354. doi：10.1016/j.psychres.2017.02.028 .
10	DENG X H， HUANG Z B， LI X W， et al. Long-term follow-up of patients treated for psychotic symptoms that persist after stopping illicit drug use[J]. Shanghai Arch Psychiatry，2012，24（5）：271-278. doi：10.3969/j.issn.1002-0829.2012.05.004 .
11	GLASNER-EDWARDS S， MOONEY L J. Methamphetamine psychosis： Epidemiology and management[J]. CNS Drugs，2014，28（12）：1115-1126. doi：10.1007/s40263-014-0209-8 .
12	ARUNOGIRI S， FOULDS J A， MCKETIN R， et al. A systematic review of risk factors for methamphetamine-associated psychosis[J]. Aust N Z J Psychiatry，2018，52（6）：514-529. doi：10.1177/000 4867417748750 .
13	DING Y Y， LIN H J， ZHOU L， et al. Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methampheta-mine - associated psychosis[J]. Drug Alcohol Dependence，2014，142：295-300. doi：10.1016/j.drugalcdep. 2014.06.042 .
14	BRAMNESS J G， GUNDERSEN Ø H， GUTERS-TAM J， et al. Amphetamine-induced psychosis -- A separate diagnostic entity or primary psychosis triggered in the vulnerable?[J]. BMC Psychiatry，2012，12：221. doi：10.1186/1471-244X-12-221 .
15	MA J， SUN X J， WANG R J， et al. Profile of psychiatric symptoms in methamphetamine users in China： Greater risk of psychiatric symptoms with a longer duration of use[J]. Psychiatry Res，2018，262：184-192. doi：10.1016/j.psychres.2018.02.017 .
16	SULAIMAN A H， SAID M A， HABIL M H， et al. The risk and associated factors of methampheta-mine psychosis in methamphetamine-dependent patients in Malaysia[J]. Compr Psychiatry，2014，55： S89-S94. doi：10.1016/j.comppsych.2013.01.003 .
17	SU M F， LIU M X， LI J Q， et al. Epidemiological characteristics and risk factors of methamphetamine-associated psychotic symptoms[J]. Front Psychiatry，2018，9：489. doi：10.3389/fpsyt.2018.00489 .
18	CRUICKSHANK C C， DYER K R. A review of the clinical pharmacology of methamphetamine[J]. Addict Abingdon Engl，2009，104（7）：1085-1099. doi：10.1111/j.1360-0443.2009.02564.x .
19	HSIEH J H， STEIN D J， HOWELLS F M. The neurobiology of methamphetamine induced psychosis[J]. Front Hum Neurosci，2014，8：537. doi：10.3389/fnhum.2014.00537 .
20	GRANT K M， LEVAN T D， WELLS S M， et al. Methamphetamine-associated psychosis[J]. J Neuroimmune Pharmacol，2012，7（1）：113-139. doi：10.1007/s11481-011-9288-1 .
21	SHIN E J， DANG D K， TRAN T V， et al. Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors[J]. Arch Pharmacal Res，2017，40（4）：403-428. doi：10.1007/s12272-017-0897-y .
22	BREEN M S， UHLMANN A， NDAY C M， et al. Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis： An integrative RNA-sequencing report[J]. Transl Psychiatry，2016，6（5）： e802. doi：10.1038/tp.2016.67 .
23	BREEN M S， UHLMANN A， OZCAN S， et al. Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis[J]. Sci Rep，2017，7：43777. doi：10.1038/srep43777 .
24	WEARNE T A， CORNISH J L. A comparison of methamphetamine-induced psychosis and schizophrenia： A review of positive， negative， and cognitive symptomatology[J]. Front Psychiatry，2018，9：491. doi：10.3389/fpsyt.2018.00491 .
25	SALO R， Structural FASSBENDER C.， functional and spectroscopic MRI studies of methamphetamine addiction[J]. Curr Top Behav Neurosci，2012，11：321-364. doi：10.1007/7854_2011_172 .
26	PIERRI J N， VOLK C L E， AUH S， et al. Somal size of prefrontal cortical pyramidal neurons in schizophrenia： Differential effects across neuronal subpopulations[J]. Biol Psychiatry，2003，54（2）：111-120. doi：10.1016/S0006-3223（03）00294-4 .
27	EASTWOOD S L， HARRISON P J. Interstitial white matter neuron density in the dorsolateral prefrontal cortex and parahippocampal gyrus in schizophrenia[J]. Schizophr Res，2005，79（2/3）：181-188. doi：10.1016/j.schres.2005.07.001 .
28	ZHANG S Y， HU Q， TANG T， et al. Changes in gray matter density， regional homogeneity， and functional connectivity in methamphetamine - associated psychosis： A resting-state functional magnetic resonance imaging （fMRI） study[J]. Med Sci Monit，2018，24：4020-4030. doi：10.12659/msm.905354 .
29	RUAN X L， ZHONG N， YANG Z， et al. Gray matter volume showed dynamic alterations in methamphetamine users at 6 and 12 months abstinence： A longitudinal voxel-based morphometry study[J]. Prog Neuro Psychopharmacol Biol Psychiatry，2018，81：350-355. doi：10.1016/j.pnpbp.2017.09.004 .
30	American Psychiatric Association. Diagnostic and statistical manual of mental disorders[M]. 5th ed. Maine： American Psychiatric Association，2013. doi：10.1176/appi.books.9780890425596
31	HAWE J S， THEIS F J， HEINIG M. Inferring interaction networks from multi-omics data[J]. Front Genet，2019，10：535. doi：10.3389/fgene.2019.00535 .
32	MIRZA B， WANG W， WANG J， et al. Machine learning and integrative analysis of biomedical big data[J]. Genes，2019，10（2）：87. doi：10.3390/genes10020087 .
33	刘伟，朱云平，贺福初. 系统生物学研究中不同组学数据的整合[J].中国生物化学与分子生物学报，2007，23（12）：971-976. doi：10.13865/j.cnki.cjbmb.2007.12.005 .
	LIU W， ZHU Y P， HE F C. Integration of various ‘omics’ data in biological systems[J]. Zhongguo Shengwuhuaxue Yu Fenzishengwu Xuebao，2007，23（12）：971-976.
34	LI H， WANG X， RUKINA D， et al. An integrated systems genetics and omics toolkit to probe gene function[J]. Cell Syst，2018，6（1）：90-102.e4. doi：10.1016/j.cels.2017.10.016 .
35	WANG D F， LIU S， WARRELL J， et al. Comprehensive functional genomic resource and integrative model for the human brain[J]. Science，2018，362（6420）： eaat8464. doi：10.1126/science.aat8464 .
36	JIANG W N， JING X， LI M， et al. Corydaline and l-tetrahydropalmatine attenuate morphine-induced conditioned place preference and the changes in dopamine D2 and GluA1 AMPA receptor expression in rats[J]. Eur J Pharmacol，2020，884：173397. doi：10.1016/j.ejphar.2020.173397 .
37	WANG Q， CHENG W， LI M， et al. The CHRM3 gene is implicated in abnormal thalamo-orbital frontal cortex functional connectivity in first-episode treatment-naive patients with schizophrenia[J]. Psychol Med，2016，46（7）：1523-1534. doi：10.1017/s0033291716000167 .
38	KIBINGE N K， RELTON C L， GAUNT T R， et al. Characterizing the causal pathway for genetic variants associated with neurological phenotypes using human brain-derived proteome data[J]. Am J Hum Genet，2020，106（6）：885-892. doi：10.1016/j.ajhg.2020.04.007 .
39	PICARDI A， VIROLI C， TARSITANI L， et al. Heterogeneity and symptom structure of schizophrenia[J]. Psychiatry Res，2012，198（3）：386-394. doi：10.1016/j.psychres.2011.12.051 .
40	COMES A L， PAPIOL S， MUELLER T， et al. Proteomics for blood biomarker exploration of severe mental illness： Pitfalls of the past and potential for the future[J]. Transl Psychiatry，2018，8：160. doi：10.1038/s41398-018-0219-2 .
41	SETHI S， BRIETZKE E. Omics-based biomarkers： Application of metabolomics in neuropsychiatric disorders[J]. Int J Neuropsychopharmacol，2015，19（3）：pyv096. doi：10.1093/ijnp/pyv096 .
42	MOORE R， CASALE F P， BONDER M JAN， et al. A linear mixed-model approach to study multivariate gene-environment interactions[J]. Nat Genet，2019，51（1）：180-186. doi：10.1038/s41588-018-0271-0 .
43	NOHESARA S， GHADIRIVASFI M， BARATI M， et al. Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes[J]. Am J Med Genet Part B Neuropsychiatr Genet，2016，171（8）：1180-1189. doi：10.1002/ajmg.b.32506 .
44	KISHI T， FUKUO Y， OKOCHI T， et al. Serotonin 6 receptor gene is associated with methamphetamine - induced psychosis in a Japanese population[J]. Drug Alcohol Depend，2011，113（1）：1-7. doi：10.1016/j.drugalcdep.2010.06.021 .
45	TSUNOKA T， KISHI T， KITAJIMA T， et al. Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population[J]. Prog Neuro Psychopharmacol Biol Psychiatry，2010，34（4）：639-644. doi：10.1016/j.pnpbp.2010.03.002 .
46	KISHI T， TSUNOKA T， IKEDA M， et al. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients[J]. Neuropharmacology，2010，58（2）：452-456. doi：10.1016/j.neuropharm.2009.09.006 .
47	KISHI T， IKEDA M， KITAJIMA T， et al. A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis[J]. Prog Neuro Psychopharmacol Biol Psychiatry，2009，33（5）：895-898. doi：10.1016/j.pnpbp.2009.04.008 .
48	HASHIMOTO T， HASHIMOTO K， MATSUZAWA D， et al. A functional glutathioneS-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population[J]. Am J Med Genet，2005，135B（1）：5-9. doi：10.1002/ajmg.b.30164 .
49	YANG X， ZHAO H， LIU X B， et al. The relationship between serum cytokine levels and the degree of psychosis and cognitive impairment in patients with methamphetamine-associated psychosis in Chinese patients[J]. Front Psychiatry，2020，11：594766. doi：10.3389/fpsyt.2020.594766 .
50	FARNIA V， FARSHCHIAN F， FARSHCHIAN N， et al. Comparisons of voxel-based morphometric brain volumes of individuals with methamphetamine-induced psychotic disorder and schizophrenia spectrum disorder and healthy controls[J]. Neuropsychobio-logy，2020，79（2）：170-178. doi：10.1159/000504576 .
51	UHLMANN A， FOUCHE J P， KOEN N， et al. Fronto-temporal alterations and affect regulation in methamphetamine dependence with and without a history of psychosis[J]. Psychiatry Res Neuroimaging，2016，248：30-38. doi：10.1016/j.pscychresns.2016.01.010 .
52	BOYLE E A， LI Y I， PRITCHARD J K. An expanded view of complex traits： From polygenic to omnigenic[J]. Cell，2017，169（7）：1177-1186. doi：10.1016/j.cell.2017.05.038 .
53	何磊. 吸毒致幻后伤人构成何罪[J].中国检察官，2019（16）：60-63.
	HE L. What is the crime of wounding after hallucination caused by drug abuse[J]. Zhongguo Jianchaguan，2019（16）：60-63.
54	GRELOTTI D J， KANAYAMA G， POPE H G. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy： Presentation of a case and review of the literature[J]. Am J Psychiatry，2010，167（1）：17-23. doi：10.1176/appi.ajp.2009.08111695 .

[1]	Wen LI, Hao-zhe LI, Chen CHEN, Wei-xiong CAI. Research Progress and Application Prospect of Facial Micro-Expression Analysis in Forensic Psychiatry [J]. Journal of Forensic Medicine, 2023, 39(5): 493-500.
[2]	Zhong-hua WANG, Shu-jin LI. Research Progress on Molecular Biology of Human Height Estimation [J]. Journal of Forensic Medicine, 2023, 39(5): 487-492.
[3]	Lu CHEN, Zhe ZHOU, Sheng-qi WANG. Process of Forensic Medicine in DNA Identification of Aged Human Remains [J]. Journal of Forensic Medicine, 2023, 39(5): 478-486.
[4]	Yong ZENG, Dong-hua ZOU, Ying FAN, Qing XU, Lu-yang TAO, Yi-jiu CHEN, Zheng-dong LI. Research Progress and Forensic Application of Human Vascular Finite Element Modeling and Biomechanics [J]. Journal of Forensic Medicine, 2023, 39(5): 471-477.
[5]	Fei FAN, Juan WU, Zhen-hua DENG. Application Progress of Objective Audiological Detection Techniques in Forensic Clinical Medicine [J]. Journal of Forensic Medicine, 2023, 39(4): 360-366.
[6]	Qing-qing XIANG, Li-fang CHEN, Qin SU, Yu-kun DU, Pei-yan LIANG, Xiao-dong KANG, He SHI, Qu-yi XU, Jian ZHAO, Chao LIU, Xiao-hui CHEN. Research Progress on Microbial Community Succession in the Postmortem Interval Estimation [J]. Journal of Forensic Medicine, 2023, 39(4): 399-405.
[7]	Yu-qi CAO, Yan SHI, Ping XIANG, Yin-long GUO. Research Progress on Machine Learning Assisted Non-Targeted Screening Strategy for Identification of Fentanyl Analogs [J]. Journal of Forensic Medicine, 2023, 39(4): 406-416.
[8]	Ran LI, Hong-yu SUN. Methods and Research Hotspots of Forensic Kinship Testing [J]. Journal of Forensic Medicine, 2023, 39(3): 231-239.
[9]	Xiao-yan MA, Hong-yu SUN, Qing LI. Research Progresses of Tri-Allelic Patterns in Autosomal STR in Forensic DNA Analysis [J]. Journal of Forensic Medicine, 2023, 39(3): 240-246.
[10]	Hang CHEN, Jing HU, Zheng QIAO, Hong-xiao DENG, Min LÜ, Wei LIU. Research Progress on Biological Matrix Reference Materials in Forensic Toxicology [J]. Journal of Forensic Medicine, 2023, 39(2): 176-185.
[11]	Hong-yan GAO, Guang-fu LIU, Jian WU, Peng-yu CHEN. Animal DNA Typing and Its Research Progress in Forensic Medicine [J]. Journal of Forensic Medicine, 2023, 39(2): 161-167.
[12]	Zhong-ping CHENG, Yan-fei LIU, Xing-min XU, Yao-nan MO. Progress in the Application of Magnetic Nanoparticles in Forensic Trace Analysis [J]. Journal of Forensic Medicine, 2023, 39(2): 168-175.
[13]	Hong-xia HAO, Ya-hui WANG, Zhi-lu ZHOU, Tai-ang LIU, Jin CHEN, Yu-heng HE, Lei WAN, Wen-tao XIA. Research Progress of Age Estimation in the Living by Knee Joint MRI [J]. Journal of Forensic Medicine, 2023, 39(1): 66-71.
[14]	Zi-wei WANG, Qian-nan XU, Cheng-tao LI, Xi-ling LIU. Age Estimation Based on DNA Methylation and Its Application Prospects in Forensic Medicine [J]. Journal of Forensic Medicine, 2023, 39(1): 72-82.
[15]	Hui WU, Fang-fang LIU, Jun-da WU, Ying XIE. Research Progress on Estimation of Postmortem Interval Based on Ocular Tissues Structure [J]. Journal of Forensic Medicine, 2023, 39(1): 50-56.